{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:39:11Z","timestamp":1762864751240},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T00:00:00Z","timestamp":1083110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s00431-004-1452-7","type":"journal-article","created":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T16:06:58Z","timestamp":1083946018000},"page":"374-377","source":"Crossref","is-referenced-by-count":24,"title":["Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome"],"prefix":"10.1007","volume":"163","author":[{"given":"Sabine","family":"Dormann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Kr\ufffdger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Rasenack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Kontny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,28]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","volume":"103","author":"Ahmed","year":"2004","unstructured":"Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O?Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P (2004) Natural history of GATA 1 mutations in Down syndrome. Blood 103: 2480?2489","journal-title":"Blood"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","volume":"24","author":"Al?Kasim","year":"2002","unstructured":"Al?Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A (2002) Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 24: 9?13","journal-title":"J Pediatr Hematol Oncol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00043426-199502000-00003","volume":"17","author":"Avet?Loiseau","year":"1995","unstructured":"Avet?Loiseau H, Mechinaud F, Harousseau JL (1995) Clonal hematologic disorders in Down syndrome. J Pediatr Hematol Oncol 17: 19?24","journal-title":"J Pediatr Hematol Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<267::AID-AJH3>3.0.CO;2-O","volume":"58","author":"Bonno","year":"1998","unstructured":"Bonno M, Azuma E, Kawasaki H, Zhang ZL, Komada Y, Hirayama M, Higashiwaga M, Umemoto M, Umemoto M, Koike T, Kato T, Tahara T, Miyazaki H, Sakurai M (1998) Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder. Am J Hematol 58: 267?272","journal-title":"Am J Hematol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1987.tb06892.x","volume":"66","author":"Coulombel","year":"1987","unstructured":"Coulombel L, Derycke M, Villeval JL, Leonard C, Breton?Gorius J, Vial M, Bourgeois P, Tchernia G (1987) Characterization of the blast cell population in two neonates with Down?s syndrome and transient myeloproliferative disorder. Br J Haematol 66: 69?76","journal-title":"Br J Haematol"},{"key":"CR6","doi-asserted-by":"crossref","unstructured":"Creutzig U, Ritter J, Vormoor J, Eschenbach C, Dickerhoff R, Burdach S, Scheel?Walter HG, K\u00fchl J, Schellong G (1990) Transient myeloproliferation and acute myeloid leukemia in infants with Down?s syndrome. Klin P\u00e4diatr 202: 253?257","DOI":"10.1055\/s-2007-1025529"},{"key":"CR7","first-page":"5","volume":"33","author":"Garel","year":"1991","unstructured":"Garel D, Mielot F, Gaulard P, Quillard J, Doomergues JP, Tchernia G (1991) Acute megakaryocytic leukaemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment. Nouv Rev Fr Hematol 33: 5?8","journal-title":"Nouv Rev Fr Hematol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1447-0756.2000.tb01326.x","volume":"26","author":"Hirashima","year":"2000","unstructured":"Hirashima C, Eguchi Y, Kohumara Y, Minatami H, Sato I (2000) Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down?s syndrome. J Obstet Gynaecol Res 26: 303?306","journal-title":"J Obstet Gynaecol Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","volume":"101","author":"Hitzler","year":"2003","unstructured":"Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A (2003) GATA 1 mutations in transient leukemia and acute megakaryoblastic leukemia in Down syndrome. Blood 101: 4301?4304","journal-title":"Blood"},{"key":"CR10","first-page":"392","volume":"15","author":"Homans","year":"1993","unstructured":"Homans AC, Verissimo AM, Vlacha V (1993) Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 15: 392?399","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<159::AID-MPO6>3.0.CO;2-A","volume":"31","author":"Schwab","year":"1998","unstructured":"Schwab M, Niemeyer CM, Schwarzer U (1998) Down syndrome, transient myeloproliferative disorder and infantile liver fibrosis. Med Pediatr Oncol 31: 159?165","journal-title":"Med Pediatr Oncol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00043426-199602000-00011","volume":"18","author":"Tchernia","year":"1996","unstructured":"Tchernia G, Lejeune F, Boccara JF, Denavit MF, Dommergues JP, Bernaudin F (1996) Erythroblastic and\/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine. J Pediatr Hematol Oncol 18: 59?62","journal-title":"J Pediatr Hematol Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jcp.48.10.973","volume":"48","author":"Yagihashi","year":"1995","unstructured":"Yagihashi N, Watanabe K, Yagihashi S (1995) Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome. J Clin Pathol 48: 973?975","journal-title":"J Clin Pathol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002779900138","volume":"79","author":"Yoshioka","year":"2000","unstructured":"Yoshioka K, Yamamoto S, Moriguchi N, Miyata H, Tsukiyama K, Isokawa S, Horiuchi F, Takemura T (2000) Over-expression of bcl?2 in transient abnormal myelopoiesis associated with Down syndrome. Ann Hematol 79: 319?321","journal-title":"Ann Hematol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00043426-199602000-00003","volume":"18","author":"Zipursky","year":"1996","unstructured":"Zipursky A (1996) The treatment of children with acute megakaryoblastic leukaemia who have Down syndrome. Pediatr Hematol Oncol 18: 10?12","journal-title":"Pediatr Hematol Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08880019209018329","volume":"9","author":"Zipursky","year":"1992","unstructured":"Zipursky A, Poon A, Doyle J (1992) Leukemia in Down syndrome: a review. Pediatr Hematol Oncol 9: 139?149","journal-title":"Pediatr Hematol Oncol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-2712(18)30133-1","volume":"19","author":"Zipursky","year":"1999","unstructured":"Zipursky A, Brown EJ, Christensen H, Doyle J (1999) Transient myeloproliferative disorder (transient leukemia) and the hematologic manifestations of Down syndrome. Clin Lab Med 19: 157?167","journal-title":"Clin Lab Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-004-1452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-004-1452-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-004-1452-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T02:36:15Z","timestamp":1585794975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-004-1452-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,28]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1007\/s00431-004-1452-7","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,28]]}}}